Breaking News
Get 50% Off 0
📈 Q2 Earnings Alert! Critical earnings dates you can't miss
See Calendar
Close

Iovance Biotherapeutics Inc (IOVA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Iovance Biotherapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.13 -0.16    -4.86%
25/07 - Closed. Currency in USD
After Hours
3.13
-0.00
-0.00%
0:57:31 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 24,935,051
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 2.97 - 3.45
Iovance Biotherapeutics 3.13 -0.16 -4.86%

IOVA Recent Sentiments

 
This page features our user's sentiments regarding the Iovance Biotherapeutics Inc share. They are displayed on both charts of different time periods and in a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Jul 25, 2025 Luis Portero   3.19 -1.88%
Jul 25, 2025 Jose Navarro Tello   3.08 +1.62%
Jul 25, 2025 Storti Marco   3.00 +4.33%
Jul 24, 2025 Massimo Stradi   3.41 -8.21%
Jul 24, 2025 Cicero Porfirio   3.38 Jul 25, 2025 @ 3.14 +7.10%
Jul 24, 2025 Geronimo Stilton   3.39 -7.67%
Jul 24, 2025 ruben pl   3.58 -12.57%
Jul 24, 2025 Felix Salan De Castro   3.65 -14.25%
Jul 24, 2025 Fatih özçelik   3.56 -12.08%
Jul 24, 2025 Antonio Gonzalez   3.64 -14.01%
Jul 24, 2025 William Aguiar   3.78 -17.20%
Jul 24, 2025 ricky mulo   4.08 -23.28%
Jul 24, 2025 حالات واتس اب يوميات...   4.03 +22.33%
Jul 23, 2025 sergio espinosa   3.97 -21.16%
Jul 23, 2025 Alessio Mei   3.97 -21.16%
Jul 23, 2025 Khaled Lamloum   4.08 -23.28%
Jul 23, 2025 Ivan bernardo   4.09 Jul 24, 2025 @ 3.97 -2.93%
Jul 23, 2025 jp pp   4.05 Jul 23, 2025 @ 4.05 0.00%
Jul 23, 2025 Alejandro Sanchez   4.00 -21.75%
Jul 23, 2025 שלמה לוברבום   3.96 +20.96%
Jul 23, 2025 David Garcia Perez   4.13 -24.21%
Jul 23, 2025 Nazzareno Nazzareno   4.19 -25.30%
Jul 23, 2025 Jeremy Bijloos   4.08 -23.28%
Jul 23, 2025 Nick   4.07 -23.10%
Jul 23, 2025 Oriol Casares Garcia   4.11 -23.84%
Jul 23, 2025 Abdullah Shmmary   4.28 -26.87%
Jul 23, 2025 Marco Franchino   4.03 -22.33%
Jul 23, 2025 joss logax   4.02 -22.14%
Jul 23, 2025 Juan Mestre   4.18 -25.12%
Jul 23, 2025 Federico Molteni   3.84 -18.49%
Jul 23, 2025 EDUARDO Perez   3.00 +4.33%
Jul 22, 2025 Roberto Sbaffi   3.05 +2.62%
Jul 22, 2025 Dror ommesi   3.03 Jul 24, 2025 @ 3.37 +11.22%
Jul 22, 2025 Cicero Porfirio   2.95 Jul 23, 2025 @ 3.99 +35.25%
Jul 22, 2025 Oscar Martinez   2.96 +5.74%
Jul 22, 2025 borotalco borotalco   2.93 +6.83%
Jul 22, 2025 José Luís Lima   2.78 +12.59%
Jul 22, 2025 David Shaul   2.78 +12.59%
Jul 22, 2025 pru coex   2.00 +56.50%
Jul 21, 2025 Yehuda Leib Fass   2.47 Jul 23, 2025 @ 4.09 +65.59%
Jul 21, 2025 ΝΙΚΟΛΑΟΣ ΠΑΠΑΔΑΚΑΚΗΣ   2.48 +26.21%
Jul 21, 2025 samuel villar perez   2.53 +23.72%
Jul 19, 2025 EDER MARIN PEREZ   2.00 Jul 21, 2025 @ 2.42 +21.00%
Jul 18, 2025 Glauco Lugli   2.38 Jul 21, 2025 @ 2.42 -1.68%
Jul 17, 2025 Murat Turkoglu   2.40 +30.42%
Jul 17, 2025 Bruno N   2.32 +34.91%
Jul 17, 2025 Giacomo Anselmi   2.32 +34.91%
Jul 16, 2025 Alessio Mei   2.01 Jul 21, 2025 @ 2.42 +20.40%
Jul 15, 2025 FRANCO MACCAGNOLA   1.79 Jul 21, 2025 @ 2.42 +35.20%
Jul 15, 2025 Abdurrahim Guzel   1.78 Jul 21, 2025 @ 2.42 +35.96%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

IOVA Comments

Write your thoughts about Iovance Biotherapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email